Moskowitz, Alison

Publications

Sort by

Co-Author Network

selected publications

Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center. Journal of the American Academy of Dermatology. 2019 Academic Article GET IT
Times cited: 32
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse. Blood cancer journal. 2019 Academic Article GET IT
Times cited: 81
Practical Treatment Approach for Angioimmunoblastic T-Cell Lymphoma. Journal of oncology practice. 2019 Information Resource GET IT
Times cited: 29
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 2019 Academic Article GET IT
Times cited: 48
Mycosis fungoides, Psoriasis und PD-1-Inhibitoren - neuer Aspekt einer bekannten Assoziation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2019 Article GET IT
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. Journal of the American Academy of Dermatology. 2019 Academic Article GET IT
Times cited: 13
Mycosis fungoides, Psoriasis and Anti-PD-1 - A New Aspect of Known Associations. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2018 Article GET IT
Times cited: 1
Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature. Chinese clinical oncology. 2018 Information Resource GET IT
Times cited: 8
Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. Journal of the European Academy of Dermatology and Venereology : JEADV. 2018 Academic Article GET IT
Times cited: 15
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood cancer journal. 2018 Academic Article GET IT
Times cited: 28
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer immunology research. 2018 Academic Article GET IT
Times cited: 76
Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma. Bone marrow transplantation. 2018 Article GET IT
Times cited: 1
The optimal regimen of brentuximab vedotin for CD30⁺ cutaneous lymphoma: are we there yet?. The British journal of dermatology. 2017 Article GET IT
Times cited: 4
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 2017 Academic Article GET IT
Times cited: 247
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma. Blood. 2017 Academic Article GET IT
Times cited: 263
Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and management. Medicine. 2017 Academic Article GET IT
Times cited: 6
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience. Leukemia & lymphoma. 2017 Academic Article GET IT
Times cited: 9
Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study. Journal of the American Academy of Dermatology. 2017 Academic Article GET IT
ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature. International journal of dermatology. 2017 Information Resource GET IT
Times cited: 17
Immunotherapy of Lymphoma and Myeloma: Facts and Hopes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Information Resource GET IT
Times cited: 26
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood. 2017 Academic Article GET IT
Times cited: 109
Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides. Pediatric dermatology. 2017 Academic Article GET IT
Times cited: 27
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 78
Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?. Current hematologic malignancy reports. 2017 Information Resource GET IT
Times cited: 5
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Academic Article GET IT
Times cited: 43
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 20
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience. International journal of radiation oncology, biology, physics. 2017 Academic Article GET IT
Times cited: 16
Targeting histone deacetylases in T-cell lymphoma. Leukemia & lymphoma. 2016 Information Resource GET IT
Times cited: 59
Long-term follow-up and management of small and medium-sized CD4⁺ T cell lymphoma and CD8⁺ lymphoid proliferations of acral sites: a multicenter experience. International journal of dermatology. 2016 Academic Article GET IT
Times cited: 35
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood. 2016 Academic Article GET IT
Times cited: 59
Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation. British journal of haematology. 2016 Academic Article GET IT
Times cited: 23
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. American journal of hematology. 2016 Academic Article GET IT
Times cited: 8
Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides. Current hematologic malignancy reports. 2016 Information Resource GET IT
Times cited: 6
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 46
Central nervous system involvement in T-cell lymphoma: A single center experience. Acta oncologica (Stockholm, Sweden). 2016 Academic Article GET IT
Times cited: 40
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2015 Academic Article GET IT
Times cited: 38
mTOR inhibition in T-cell lymphoma: a path(way) forward. Blood. 2015 Article GET IT
Times cited: 3
PET-adapted salvage therapy for Hodgkin's lymphoma--authors' reply. The Lancet. Oncology. 2015 Article GET IT
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. The Lancet. Oncology. 2015 Academic Article GET IT
Times cited: 152
Other new agents for Hodgkin lymphom. Hematologic Malignancies. 2015 Article GET IT
New frontiers for brentuximab vedotin for lymphomas. Leukemia & lymphoma. 2014 Article GET IT
Times cited: 4
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study. Journal of the American Academy of Dermatology. 2014 Academic Article GET IT
Times cited: 21
Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face. The American Journal of dermatopathology. 2014 Academic Article GET IT
Times cited: 19
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood. 2014 Article GET IT
Times cited: 53
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014 Academic Article GET IT
Times cited: 116
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Journal of the American Academy of Dermatology. 2014 Information Resource GET IT
Times cited: 223
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Journal of the American Academy of Dermatology. 2014 Information Resource GET IT
Times cited: 156
Bendamustine: a bridge to longer term solutions in heavily treated Hodgkin lymphoma. Leukemia & lymphoma. 2013 Article GET IT
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission. Clinical lymphoma, myeloma & leukemia. 2013 Academic Article GET IT
Times cited: 32
Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. Journal of the American Academy of Dermatology. 2013 Information Resource GET IT
Times cited: 70
Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Journal of the American Academy of Dermatology. 2013 Information Resource GET IT
Times cited: 37
A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides. Journal of the American Academy of Dermatology. 2013 Academic Article GET IT
Times cited: 29
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 173
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long. Cancer journal (Sudbury, Mass.). 2012 Information Resource GET IT
Times cited: 8
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood. 2011 Academic Article GET IT
Times cited: 251
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. British journal of haematology. 2011 Academic Article GET IT
Times cited: 29
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood. 2010 Academic Article GET IT
Times cited: 216
The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma. Applied immunohistochemistry & molecular morphology : AIMM. 2010 Academic Article GET IT
Times cited: 38
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging. British journal of haematology. 2010 Academic Article GET IT
Times cited: 86
Controversies in the treatment of lymphoma with autologous transplantation. The oncologist. 2009 Information Resource GET IT
Times cited: 20
Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma. British journal of haematology. 2009 Academic Article GET IT
Times cited: 134
Posterior reversible encephalopathy syndrome due to sirolimus. Bone marrow transplantation. 2007 Article GET IT
Times cited: 25

more ...

less ...

Background

education and training

M.D., Albert Einstein College of Medicine of Yeshiva University 2003
B.S., Cornell University 1999

Contact

full name

Alison Moskowitz

VIVO Weill Cornell Medical College

Alison Moskowitz Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name